G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	204	158	275	434	684	993
Market Cap Growth	62.88%	-42.46%	-36.70%	-36.57%	-31.09%	39.49%
Enterprise Value	188	120	234	259	475	704
Last Close Price	4.32	3.05	5.43	10.21	17.99	26.43
PE Ratio	-	-3.28	-1.61	-2.88	-6.87	-8.09
PS Ratio	2.45	1.92	5.36	13.79	15.11	-
PB Ratio	7.43	4.47	4.00	3.02	3.86	3.89
P/FCF Ratio	-12.40	-4.12	-2.13	-3.29	-8.17	-9.71
P/OCF Ratio	-12.40	-4.12	-2.14	-3.29	-8.17	-9.98
EV/Sales Ratio	2.23	1.45	4.57	8.24	10.49	-
EV/EBITDA Ratio	-8.98	-3.07	-1.73	-1.83	-4.95	-5.47
EV/EBIT Ratio	-8.78	-3.03	-1.72	-1.82	-4.92	-5.45
EV/FCF Ratio	-11.03	-3.12	-1.81	-1.96	-5.67	-6.88
Debt / Equity Ratio	1.70	1.62	1.20	0.57	0.16	0.04
Debt / FCF Ratio	-2.59	-1.49	-0.64	-0.62	-0.33	-0.10
Asset Turnover	0.64	0.53	0.23	0.13	0.18	-
Inventory Turnover	0.49	0.50	0.38	-	-	-
Quick Ratio	2.36	3.19	4.39	8.22	8.85	13.62
Current Ratio	2.94	3.87	5.04	8.82	9.23	13.71
Return on Equity (ROE)	-84.13%	-92.13%	-139.02%	-92.46%	-45.86%	-39.86%
Return on Assets (ROA)	-10.81%	-15.96%	-38.51%	-36.89%	-23.49%	-24.58%
Return on Capital (ROIC)	-14.09%	-20.25%	-45.17%	-41.36%	-25.61%	-25.83%
Earnings Yield	-14.85%	-30.34%	-53.69%	-34.17%	-14.50%	-12.33%
FCF Yield	-8.83%	-24.25%	-46.99%	-30.43%	-12.23%	-10.30%
Buyback Yield / Dilution	-1.01%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%
Total Shareholder Return	-1.01%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%

Source: S&P Capital IQ. Standard template.